[
  {
    "ts": null,
    "headline": "Cencora (COR) Stock Trades Up, Here Is Why",
    "summary": "Shares of healthcare distributor Cencora (NYSE:COR) jumped 7.1% in the afternoon session after the company reported first-quarter results that beat profit expectations and raised its full-year guidance.",
    "url": "https://finnhub.io/api/news?id=ef2b318337d1bd9ac27ac8298f7293f4abf083f26ae9dfe85a562f0520404136",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770323460,
      "headline": "Cencora (COR) Stock Trades Up, Here Is Why",
      "id": 138368824,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Shares of healthcare distributor Cencora (NYSE:COR) jumped 7.1% in the afternoon session after the company reported first-quarter results that beat profit expectations and raised its full-year guidance.",
      "url": "https://finnhub.io/api/news?id=ef2b318337d1bd9ac27ac8298f7293f4abf083f26ae9dfe85a562f0520404136"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right.",
    "summary": "Less than a month after raising its fiscal-year outlook,  Cardinal Health  hiked it again.  The company, which distributes pharmaceuticals and other medical supplies to customers like  CVS Health  said Thursday that it now expects adjusted earnings in the range of $10.15 to $10.35 a share for the current fiscal year.  The new range also is above the $10.02 a share analysts are expecting, according to FactSet.",
    "url": "https://finnhub.io/api/news?id=04ece9ef323b78c73d17f32f976aa7418957e6bdfb7f6cde4a746f071f79ac5e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770313680,
      "headline": "Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right.",
      "id": 138367470,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Less than a month after raising its fiscal-year outlook,  Cardinal Health  hiked it again.  The company, which distributes pharmaceuticals and other medical supplies to customers like  CVS Health  said Thursday that it now expects adjusted earnings in the range of $10.15 to $10.35 a share for the current fiscal year.  The new range also is above the $10.02 a share analysts are expecting, according to FactSet.",
      "url": "https://finnhub.io/api/news?id=04ece9ef323b78c73d17f32f976aa7418957e6bdfb7f6cde4a746f071f79ac5e"
    }
  },
  {
    "ts": null,
    "headline": "Cencora Q1 Earnings Call Highlights",
    "summary": "Cencora (NYSE:COR) reported a strong start to fiscal 2026 and raised key elements of its full-year outlook after completing the acquisition of a majority stake in OneOncology. Management highlighted continued momentum in the company’s U.S. Healthcare Solutions segment, benefits from its pharmaceutic",
    "url": "https://finnhub.io/api/news?id=3782f443e05aaa2a2c06cc07569fbde42c804aa5cbeb07e8dedf2edec46954e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770271991,
      "headline": "Cencora Q1 Earnings Call Highlights",
      "id": 138361582,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Cencora (NYSE:COR) reported a strong start to fiscal 2026 and raised key elements of its full-year outlook after completing the acquisition of a majority stake in OneOncology. Management highlighted continued momentum in the company’s U.S. Healthcare Solutions segment, benefits from its pharmaceutic",
      "url": "https://finnhub.io/api/news?id=3782f443e05aaa2a2c06cc07569fbde42c804aa5cbeb07e8dedf2edec46954e3"
    }
  },
  {
    "ts": null,
    "headline": "COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts",
    "summary": "Healthcare distributor Cencora (NYSE:COR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=0f8f3787914a8e4b76f3cceccbfcb537b182ac71f9ba390842207c0d29629f63",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770269671,
      "headline": "COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts",
      "id": 138362795,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Healthcare distributor Cencora (NYSE:COR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=0f8f3787914a8e4b76f3cceccbfcb537b182ac71f9ba390842207c0d29629f63"
    }
  }
]